Assembly Biosciences Inc expected to post a loss of 48  cents a share - Earnings Preview

Assembly Biosciences

21/02/2022 12:26

* Assembly Biosciences Inc  ASMB.OQ   ASMB.O  is expected
to show
a rise in quarterly revenue when it reports  results on February
23 (estimated). 
    * The South San Francisco California-based  company is
expected to
report  a 20.6% increase in revenue to $1.251 million from $1.04
million a year ago, according to the mean estimate from 5
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Assembly
Biosciences Inc
is for a loss of 48 cents per share. For the same quarter last
year, the company reported a loss of 96 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Assembly
Biosciences Inc is $14​, about 88.9% above​ its last closing
price of $1.55. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2021  -0.55       -0.56      -0.41     Beat    26.6
 Jun. 30 2021  -0.65       -0.66      -0.55     Beat    16.2
 Mar. 31 2021  -0.78       -0.79      -0.69     Beat    12.2​
 Dec. 31 2020  -0.90       -0.90      -0.96     Missed  -6.2
 ​​Sep.        -0.73       -0.75      -0.09     Beat    88
 30 2020                                                
 Jun. 30 2020  0.24        -0.03      0.19      Beat    733.3​
 Mar. 31 2020  -1.00       -0.98      -0.76     Beat    22.3
 Dec. 31 2019  -0.98       -1.01      -0.99     Beat    1.7
 This summary was machine generated February 21 at 12:26 GMT. 
All figures in US dollars  unless otherwise stated